-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRUM PHARMACEUTICALS, INC. : LEERINK PARTNERS CUTS TARGET PRICE TO $140 FROM $154

Reuters·11/04/2026 03:41:27

Please log in to view news